Single-Use Bioreactors Have Reached the Big Time

News
Article
Pharmaceutical TechnologyPharmaceutical Technology-05-15-2017
Volume 2017 eBook
Issue 1
Pages: s13-s17

The decision to use disposable bioreactors is now driven by commercial rather than technological considerations.

Dramatic increases in protein titers from cell culture processes have enabled downsizing of upstream bioprocesses and facilitated the adoption of single-use bioreactors for biopharmaceutical manufacturing.

Manufacturers of disposable bioreactors have continually worked to improve their systems to meet evolving needs for biologic drug substance production.

This article explores recent advances in disposable bioreactor technology, the limitations that remain, and efforts that are underway to address them.

Download

Pharmaceutical Technology’s 2017 Biologics and Sterile Drug Manufacturing eBook

.

 

 

 

Recent Videos
Drug Digest: Strategic Partnerships
Michelle Bridenbaker from Unbiased Science discusses her thoughts on the key industry from 2024 and those she anticipates will impact the industry in 2025 and beyond.
Tore Bergsteiner from MAIN5 discusses the most pertinent and impactful bio/pharma industry trends from 2024.
Related Content